{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:34:13Z","timestamp":1791902053685,"version":"4.3.4"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T00:00:00Z","timestamp":1447200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142605","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T18:56:34Z","timestamp":1447268194000},"page":"e0142605","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials"],"prefix":"10.1371","volume":"10","author":[{"given":"Alessandro","family":"Belletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Musu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Silvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludhmila A.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Fominskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zangrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ALN.0b013e3182a10e26","article-title":"Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension","volume":"119","author":"M Walsh","year":"2013","journal-title":"Anesthesiology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13054-015-0794-z","article-title":"Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature","volume":"19","author":"M Leone","year":"2015","journal-title":"Crit Care"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"RP Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","article-title":"Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function","volume":"33","author":"A Bourgoin","year":"2005","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"D De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"MW D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00134-012-2531-2","article-title":"Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study","volume":"38","author":"CA Schmittinger","year":"2012","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-010-2045-8","article-title":"Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside","volume":"36","author":"B Levy","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"DW Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"JA Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"ref11","first-page":"654708","article-title":"Therapeutic strategies for high-dose vasopressor-dependent shock","volume":"2013","author":"E Bassi","year":"2013","journal-title":"Crit Care Res Pract"},{"key":"ref12","first-page":"42","article-title":"Methylene blue as a vasopressor: a meta-analysis of randomised trials","volume":"15","author":"L Pasin","year":"2013","journal-title":"Crit Care Resusc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1089253210379271","article-title":"Vasopressin and methylene blue: alternate therapies in vasodilatory shock","volume":"14","author":"D Lavigne","year":"2010","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.athoracsur.2006.08.041","article-title":"Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review","volume":"83","author":"M Egi","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ije\/dyh311","article-title":"A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials","volume":"34","author":"GG Biondi-Zoccai","year":"2005","journal-title":"Int J Epidemiol"},{"key":"ref16","article-title":"Version 5.1.0 [updated March 2011]","author":"JPT Higgins","year":"2011"},{"key":"ref17","first-page":"93","article-title":"A journey into clinical evidence: from case reports to mixed treatment comparisons","volume":"3","author":"G Biondi-Zoccai","year":"2011","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"ref18","first-page":"161","article-title":"The rough guide to systematic reviews and meta-analyses","volume":"3","author":"G Biondi-Zoccai","year":"2011","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref20","first-page":"219","article-title":"Meta-analysis: pitfalls and hints","volume":"5","author":"T Greco","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study","volume":"33","author":"J Alban\u00e8se","year":"2005","journal-title":"Crit Care Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00268-010-0875-8","article-title":"Impact of low-dose vasopressin on trauma outcome: prospective randomized study","volume":"35","author":"SM Cohn","year":"2011","journal-title":"World J Surg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"MW D\u00fcnser","year":"2003","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.jvca.2009.08.001","article-title":"Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery","volume":"24","author":"S Hasija","year":"2010","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jemermed.2012.02.073","article-title":"Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock","volume":"44","author":"F Hua","year":"2013","journal-title":"J Emerg Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"MY Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial","volume":"32","author":"F Lauzier","year":"2006","journal-title":"Intensive Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"RL Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/cc4845","article-title":"Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome","volume":"10","author":"G Luckner","year":"2006","journal-title":"Crit Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"MB Malay","year":"1999","journal-title":"J Trauma"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"AD Maslow","year":"2006","journal-title":"Anesth Analg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"D Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0003-4975(02)04408-9","article-title":"A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass","volume":"75","author":"DL Morales","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"A Morelli","year":"2008","journal-title":"Br J Anaesth"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study","volume":"13","author":"A Morelli","year":"2009","journal-title":"Crit Care"},{"key":"ref36","article-title":"Vasopressin Does Not Raise Cardiac Enzymes Following Cardiac Surgery: A Randomized Double-Blind Clinical Trial","author":"Y Okamoto","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"E Ozal","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8090-5-17","article-title":"Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study","volume":"5","author":"G Papadopoulos","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"ref39","first-page":"1043","article-title":"Terlipressin in the treatment of late phase catecholamine-resistant septic shock","volume":"59","author":"P Svoboda","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"DC Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","article-title":"Critical care and the global burden of critical illness in adults","volume":"376","author":"NK Adhikari","year":"2010","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/CCM.0000000000000520","article-title":"Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study","volume":"42","author":"J Waechter","year":"2014","journal-title":"Crit Care Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc5086","article-title":"Causes of death and determinants of outcome in critically ill patients","volume":"10","author":"VD Mayr","year":"2006","journal-title":"Crit Care"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF01701473","article-title":"Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay","volume":"21","author":"T Saito","year":"1995","journal-title":"Intensive Care Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: Vasopressin in the management of septic shock","volume":"15","author":"JA Russell","year":"2011","journal-title":"Crit Care"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","article-title":"Vasopressin: mechanisms of action on the vasculature in health and in septic shock","volume":"35","author":"LK Barrett","year":"2007","journal-title":"Crit Care Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"JA Russell","year":"2009","journal-title":"Crit Care Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00134-002-1265-y","article-title":"Cardiac performance during vasopressin infusion in postcardiotomy shock","volume":"28","author":"MW D\u00fcnser","year":"2002","journal-title":"Intensive Care Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"AC Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial","volume":"42","author":"AC Gordon","year":"2014","journal-title":"Crit Care Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e005866","DOI":"10.1136\/bmjopen-2014-005866","article-title":"Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)","volume":"4","author":"AC Gordon","year":"2014","journal-title":"BMJ Open"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1517\/14656560903257808","article-title":"Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock","volume":"10","author":"A Morelli","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","article-title":"Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis","volume":"34","author":"M Lange","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"A Serpa Neto","year":"2012","journal-title":"Crit Care"},{"issue":"Suppl I","key":"ref55","first-page":"22","article-title":"Novel actions of methylene blue","volume":"14","author":"B Mayer","year":"1993","journal-title":"Eur Heart J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13181-013-0298-7","article-title":"Methylene blue for distributive shock: a potential new use of an old antidote","volume":"9","author":"DH Jang","year":"2013","journal-title":"J Med Toxicol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock","volume":"27","author":"MM Weiner","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1053\/j.jvca.2013.12.012","article-title":"Methylene blue: between scylla (meta-analysis) and charybdis (propensity)","volume":"28","author":"G Landoni","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref59","article-title":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials","author":"A Zangrillo","year":"2015","journal-title":"J Crit Care"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/CCM.0b013e3181ef4694","article-title":"Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock","volume":"38","author":"S Rehberg","year":"2010","journal-title":"Crit Care Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-011-2407-x","article-title":"Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis","volume":"38","author":"A Polito","year":"2012","journal-title":"Intensive Care Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"S Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"ref63","article-title":"The Blue Coma: the role of methylene blue in unexplained coma after cardiac surgery. A case series","author":"EA Martino","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T12:57:06Z","timestamp":1567342626000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142605"}},"subtitle":[],"editor":[{"given":"Zaccaria","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,11]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142605","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,11]]}}}